Israeli Medical Device Company WhiteSwell Raises $30 Million
WhiteSwell will use the funding to develop its catheter-based technology to treat a condition related to heart failure
For daily updates, subscribe to our newsletter by clicking here.
Founded in 2014 by chief technology officer Yaacov Nitzan, Israel-based WhiteSwell develops a minimally invasive catheter-based method for removing excess fluids from the lungs and other organs.
Hospitalization (illustration). Photo: Shutterstock
The company said it will use the recent funding to develop its treatment for acute decompensated heart failure (ADHF), a condition that occurs when a failing heart cannot circulate fluids in the body efficiently, causing severe fluid buildup in multiple organs. A 2016 study published in the American Journal of Epidemiology found that ADHF is responsible for nearly two million hospitalizations a year just in the U.S.
- Natural Language Startup Voca AI Raises $2.6 Million
- Qualcomm Sets Up $100 Million AI Fund, Invests in AI Startup AnyVision
- WeWork’s Adam Neumann Invests in Ehud Barak’s Cannabis Venture
WhiteSwell is currently conducting an early feasibility study for the treatment at clinical sites in the U.S., Israel, and Europe.
